Elevidys™ (delandistrogene moxeparvovec-rokl)
| Full Name | Elevidys™ (delandistrogene moxeparvovec-rokl) |
| Drug | Elevidys |
| Manufacturer | Sarepta Therapeutics, Inc. |
| Route of Administration | Intravenous |
| Site of Care | Healthcare Facility |
| Approved Indication | Treatment of adult patients with symptomatic gene mutation confirmed limb-girdle muscular dystrophy type R5 (LGMDR5) |
| Disease | Limb-Girdle Muscular Dystrophy Type R5 (LGMDR5) |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-240-9572 |
| Fax Number | 877-220-7581 |
| Product Website | elevidyshcp.com |